696
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Decreasing national trends in diabetic complications hide regional differences: a prospective population-based study using health care registers in Finland

ORCID Icon, ORCID Icon & ORCID Icon
Article: 2247190 | Received 16 Mar 2023, Accepted 08 Aug 2023, Published online: 23 Aug 2023

References

  • Harding JL, Pavkov ME, Magliano DJ, et al. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16. doi:10.1007/s00125-018-4711-2.
  • Ford ES. Trends in the risk for coronary heart disease among adults with diagnosed diabetes in the U.S.: findings from the National Health and Nutrition Examination Survey, 1999–2008. Diabetes Care. 2011;34(6):1337–1343. doi:10.2337/dc10-2251.
  • Wong ND, Zhao Y, Patel R, et al. Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the atherosclerosis risk in communities study, multi-ethnic study of atherosclerosis, and Jackson heart study. Diabetes Care. 2016;39(5):668–676. doi:10.2337/dc15-2439.
  • Ali MK, Pearson-Stuttard J, Selvin E, et al. Interpreting global trends in type 2 diabetes complications and mortality. Diabetologia. 2022;65(1):3–13. doi:10.1007/s00125-021-05585-2.
  • Heintjes EM, Houben E, Beekman-Hendriks WL, et al. Trends in mortality, cardiovascular complications, and risk factors in type 2 diabetes. Neth J Med. 2019;77(9):317–329.
  • Wilmot EG, Davies MJ, Yates T, et al. Type 2 diabetes in younger adults: the emerging UK epidemic. Postgrad Med J. 2010;86(1022):711–718. doi:10.1136/pgmj.2010.100917.
  • Saeedi P, Petersohn I, Salpea P, IDF Diabetes Atlas Committee., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843., doi:10.1016/j.diabres.2019.107843.
  • Sattar N, Rawshani A, Franzén S, et al. Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks. Circulation. 2019;139(19):2228–2237. doi:10.1161/CIRCULATIONAHA.118.037885.
  • Rawshani A, Sattar N, Franzén S, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 2018;392(10146):477–486. doi:10.1016/S0140-6736(18)31506-X.
  • Grimaldi A, Heurtier A. Epidémiologie des complications cardio-vasculaires du diabète [epidemiology of cardio-vascular complications of diabetes] (in French). Diabetes Metab. 1999;25(Suppl 3):12–20.
  • Kurani SS, Lampman MA, Funni SA, et al. Association between area-level socioeconomic deprivation and diabetes care quality in US primary care practices. JAMA Netw Open. 2021;4(12):e2138438. doi:10.1001/jamanetworkopen.2021.38438.
  • Winell K, Arffman M, Salomaa V. Significant regional differences in the incidence of acute coronary syndromes and strokes among diabetic patients in Finland (in Finnish). Duodecim. 2020;136(5):561–568.
  • Winell K, Arffman M, Pietilä A, et al. Regional differences in the incidence of diabetic cardiovascular events reflect the quality of care. Scand Cardiovasc J. 2018;52(5):232–237. doi:10.1080/14017431.2018.1497198.
  • Fox CS, Matsushita K, Woodward M, Chronic Kidney Disease Prognosis Consortium., et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis [published correction appears in lancet 2013;381:374]. Lancet. 2012;380(9854):1662–1673., doi:10.1016/S0140-6736(12)61350-6.
  • Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014;37(10):2864–2883. doi:10.2337/dc14-1296.
  • Zinman B, Wanner C, Lachin JM, EMPA-REG OUTCOME Investigators., et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117–2128., doi:10.1056/NEJMoa1504720.
  • Kristensen SL, Rørth R, Jhund PS, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol. 2019;7(10):776–785. doi:10.1016/S2213-8587(19)30249-9.
  • Type 2 diabetes. Current Care Guidelines. 2020). In Finnish. (cited 2023 June 12). Available from: https://www.kaypahoito.fi/hoi50056#K1.
  • Arffman M, Ilanne-Parikka P, Keskimäki I, et al. FinDM database on diabetes in Finland. Discussion paper: 2020_019. (cited 2022 Jun 7) Available from http://urn.fi/URN:ISBN:978-952-343-492-9. .
  • Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139. doi:10.1097/01.mlr.0000182534.19832.83.
  • R Development Core Team R. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2018. Available from http://www.R-project.org (cited 2022 June 7).
  • Wu H, Lau ESH, Yang A, et al. Trends in diabetes-related complications in Hong Kong, 2001–2016: a retrospective cohort study. Cardiovasc Diabetol. 2020;19(1):60. doi:10.1186/s12933-020-01039-y.
  • Wu H, Yang A, Lau ESH, et al. Secular trends in rates of hospitalisation for lower extremity amputation and 1 year mortality in people with diabetes in Hong Kong, 2001–2016: a retrospective cohort study. Diabetologia. 2020;63(12):2689–2698. doi:10.1007/s00125-020-05278-2.
  • Bennet L, Nilsson C, Mansour-Aly D, et al. Adult-onset diabetes in Middle Eastern immigrants to Sweden: novel subgroups and diabetic complications – the all new diabetes in Scania cohort diabetic complications and ethnicity. Diabetes Metab Res Rev. 2021;37(6):e3419. doi:10.1002/dmrr.3419.
  • Carinci F, Uccioli L, Massi Benedetti M, et al. An in-depth assessment of diabetes-related lower extremity amputation rates 2000–2013 delivered by twenty-one countries for the data collection 2015 of the Organization for Economic Cooperation and Development (OECD). Acta Diabetol. 2020;57(3):347–357. https:/ doi:10.1007/s00592-019-01423-5.
  • Lee W, Lloyd JT, Giuriceo K, et al. Systematic review and meta-analysis of patient race/ethnicity, socioeconomics, and quality for adult type 2 diabetes. Health Serv Res. 2020;55(5):741–772. doi:10.1111/1475-6773.13326.
  • Sikiö M, Tykkyläinen M, Tirkkonen H, et al. Type 2 diabetes care in North Karelia Finland: do area-level socio-economic factors affect processes and outcomes? Diabetes Res Clin Pract. 2014;106(3):496–503. doi:10.1016/j.diabres.2014.09.023.
  • GBD US Health Disparities Collaborators. Life expectancy by county, race, and ethnicity in the USA, 2000–19: a systematic analysis of health disparities. Lancet. 2022;400(10345):25–38. doi:10.1016/S0140-6736(22)00876-5.
  • Havulinna AS, Pääkkönen R, Karvonen M, et al. Geographic patterns of incidence of ischemic stroke and acute myocardial infarction in Finland during 1991–2003. Ann Epidemiol. 2008;18(3):206–213. doi:10.1016/j.annepidem.2007.10.008.
  • Bihrmann K, Gislason G, Larsen ML, et al. Joint mapping of cardiovascular diseases: comparing the geographic patterns in incident acute myocardial infarction, stroke and atrial fibrillation, a Danish register-based cohort study 2014-15. Int J Health Geogr. 2021;20(1):41. doi:10.1186/s12942-021-00294-w.
  • Vähämurto L, Pahkala K, Magnussen CG, et al. Coronary heart disease risk factor levels in Eastern and Western Finland from 1980 to 2011 in the cardiovascular risk in Young Finns study. Atherosclerosis. 2019;280:92–98. doi:10.1016/j.atherosclerosis.2018.11.007.
  • Adamsson Eryd S, Gudbjörnsdottir S, Manhem K, et al. Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study. BMJ. 2016;354:i4070. PMID: 27492939; PMCID: PMC4975020. doi:10.1136/bmj.i4070.
  • Laakso M, Rönnemaa T, Pyörälä K, et al. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care. 1988;11(6):449–463. PMID: 3402300. doi:10.2337/diacare.11.6.449.
  • Einarson TR, Acs A, Ludwig C, et al. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):83. doi:10.1186/s12933-018-0728-6.